ADHD drug makers move to expand into adult marketBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f7581 (Published 17 December 2013) Cite this as: BMJ 2013;347:f7581
- Michael McCarthy
After boosting the number of children taking drugs for attention-deficit/hyperactivity disorder (ADHD) nearly sixfold over two decades, from 600 000 in 1990 to 3.5 million today, US drug makers are now using the same marketing strategies to target the much larger adult market, reports a front page story in last Sunday’s New York Times.1
In the article, headlined “The selling of attention deficit disorder,” the reporter Alan Schwarz wrote that behind the growth in ADHD prescriptions in the United States …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial